Les r??sistances aux??m??dicaments antipaludiques, M??decine et Maladies Infectieuses, vol.36, issue.8, pp.401-405, 2006. ,
DOI : 10.1016/j.medmal.2006.05.005
Preventing antimalarial drug resistance through combinations, Drug Resistance Updates, vol.1, issue.1, pp.3-9, 2001. ,
DOI : 10.1016/S1368-7646(98)80208-2
Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria, Nature Reviews Microbiology, vol.7, pp.864-874, 2009. ,
DOI : 10.1038/nrmicro2239
Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial, The Lancet, vol.355, issue.9201, pp.352-357, 2000. ,
DOI : 10.1016/S0140-6736(99)10237-X
Efficacy and safety of artesunate plus amodiaquine in routine use for the treatment of uncomplicated malaria in Casamance, southern Senegal, Malaria Journal, vol.6, issue.1, p.150, 2007. ,
DOI : 10.1186/1475-2875-6-150
Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treating Uncomplicated Malaria: A Randomized Trial to Guide Policy in Uganda, PLoS ONE, vol.360, issue.6, p.2390, 2008. ,
DOI : 10.1371/journal.pone.0002390.s002
An open label randomized comparison of mefloquine?artesunate as separate tablets vs. a new co-formulated combination for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand, Tropical Medicine and International Health, vol.60, issue.11, pp.1653-1660, 2006. ,
DOI : 10.1016/S0140-6736(00)02505-8
An Open Label, Randomised Trial of Artesunate+Amodiaquine, Artesunate+Chlorproguanil-Dapsone and Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria, PLoS ONE, vol.363, issue.1, p.2530, 2008. ,
DOI : 10.1371/journal.pone.0002530.s002
Artemether???Lumefantrine versus Dihydroartemisinin???Piperaquine for Falciparum Malaria: A Longitudinal, Randomized Trial in Young Ugandan Children, Clinical Infectious Diseases, vol.49, issue.11, pp.1629-1637, 2009. ,
DOI : 10.1086/647946
Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial, The Lancet, vol.375, issue.9724, pp.1457-1467, 2010. ,
DOI : 10.1016/S0140-6736(10)60322-4
Changes in the Treatment Responses to Artesunate-Mefloquine on the Northwestern Border of Thailand during 13 Years of Continuous Deployment, PLoS ONE, vol.320, issue.2, p.4451, 2009. ,
DOI : 10.1371/journal.pone.0004551.t006
Malaria, New England Journal of Medicine, vol.361, issue.5, pp.455-467, 2009. ,
DOI : 10.1056/NEJMoa0808859
URL : https://hal.archives-ouvertes.fr/hal-01199794
Evidence of Artemisinin-Resistant Malaria in Western Cambodia, New England Journal of Medicine, vol.359, issue.24, pp.2619-2620, 2008. ,
DOI : 10.1056/NEJMc0805011
Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia, Malaria Journal, vol.8, issue.1, p.10, 2009. ,
DOI : 10.1186/1475-2875-8-10
Selection of Parasites with Diminished Drug Susceptibility by Amodiaquine???Containing Antimalarial Regimens in Uganda, The Journal of Infectious Diseases, vol.200, issue.11, pp.1650-1657, 2009. ,
DOI : 10.1086/647988
Synchronization of Plasmodium falciparum Erythrocytic Stages in Culture, The Journal of Parasitology, vol.65, issue.3, pp.418-420, 1979. ,
DOI : 10.2307/3280287
Genetic diversity and structure of African Plasmodium falciparum populations in urban and rural areas, Am J Trop Med Hyg, vol.74, pp.953-959, 2006. ,
Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates, Am J Trop Med Hyg, vol.75, pp.146-151, 2006. ,
Absence of association between pyronaridine in vitro responses and polymorphisms in genes involved in quinoline resistance in Plasmodium falciparum, Malaria Journal, vol.9, issue.1, p.337, 2010. ,
DOI : 10.1186/1475-2875-9-339
Clinical study of pyronaridine for the treatment of acute uncomplicated falciparum malaria in Thailand, Am J Trop Med Hyg, vol.54, pp.205-209, 1996. ,
In vitro activities of pyronaridine, alone and in combination with other antimalarial drugs, against Plasmodium falciparum, Antimicrob Agents Chemother, vol.43, pp.1525-1527, 1999. ,
In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays, Malaria Journal, vol.8, issue.1, p.79, 2009. ,
DOI : 10.1186/1475-2875-8-79
In-vitro activity of pyronaridine and amodiaquine against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial agents., Journal of Antimicrobial Chemotherapy, vol.42, issue.3, pp.333-339, 1998. ,
DOI : 10.1093/jac/42.3.333
In vitro susceptibility of African isolates of Plasmodium falciparum from Gabon to pyronaridine, Am J Trop Med Hyg, vol.60, pp.105-108, 1999. ,
In vitro activity of iron-binding compounds against Senegalese isolates of Plasmodium falciparum, Journal of Antimicrobial Chemotherapy, vol.57, issue.6, pp.1093-1099, 2006. ,
DOI : 10.1093/jac/dkl117
In Vitro Activity of Pyronaridine against Multidrug-Resistant Plasmodium falciparum and Plasmodium vivax, Antimicrobial Agents and Chemotherapy, vol.54, issue.12, pp.5146-5150, 2010. ,
DOI : 10.1128/AAC.00801-10
In Vitro Interactions between Piperaquine, Dihydroartemisinin, and Other Conventional and Novel Antimalarial Drugs, vitro interactions between piperaquine, dihydroartemisinin, and other conventional and novel antimalarial drugs, pp.2883-2885, 2006. ,
DOI : 10.1128/AAC.00177-06
Anti-malarial efficacy of pyronaridine and artesunate in combination in vitro and in vivo, Acta Tropica, vol.105, issue.3, pp.222-228, 2008. ,
DOI : 10.1016/j.actatropica.2007.12.005
Fixed???Dose Pyronaridine???Artesunate Combination for Treatment of Uncomplicated Falciparum Malaria in Pediatric Patients in Gabon, The Journal of Infectious Diseases, vol.198, issue.6, pp.911-919, 2008. ,
DOI : 10.1086/591096
In vitro activity of pyronaridine against field isolates and reference clones of Plasmodium falciparum, Am J Trop Med Hyg, vol.38, pp.24-29, 1988. ,
Reduced in vitro susceptibility to artemisinin derivatives associated with multi-resistance in a traveller returning from South-East Asia, Malaria Journal, vol.10, issue.1, p.268, 2011. ,
DOI : 10.1128/AAC.45.6.1746-1750.2001
URL : https://hal.archives-ouvertes.fr/inserm-00629634
In Vitro Interactions between Piperaquine, Dihydroartemisinin, and Other Conventional and Novel Antimalarial Drugs, vitro interactions between piperaquine, dihydroartemisinin, and other conventional and novel antimalarial drugs, pp.2883-2885, 2006. ,
DOI : 10.1128/AAC.00177-06
Effects of Piperaquine, Chloroquine, and Amodiaquine on Drug Uptake and of These in Combination with Dihydroartemisinin against Drug-Sensitive and -Resistant Plasmodium falciparum Strains, Antimicrobial Agents and Chemotherapy, vol.51, issue.6, pp.2265-2267, 2007. ,
DOI : 10.1128/AAC.01479-06
Role of Known Molecular Markers of Resistance in the Antimalarial Potency of Piperaquine and Dihydroartemisinin In Vitro, Antimicrobial Agents and Chemotherapy, vol.53, issue.4, pp.1362-1366, 2009. ,
DOI : 10.1128/AAC.01656-08
In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models, Experimental Parasitology, vol.115, issue.3, pp.296-300, 2007. ,
DOI : 10.1016/j.exppara.2006.09.016
Population Pharmacokinetics of Piperaquine after Two Different Treatment Regimens with Dihydroartemisinin-Piperaquine in Patients with Plasmodium falciparum Malaria in Thailand, Antimicrobial Agents and Chemotherapy, vol.52, issue.3, pp.1052-1061, 2008. ,
DOI : 10.1128/AAC.00955-07
An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia, PLoS ONE, vol.7, issue.7, p.11880, 2010. ,
DOI : 10.1371/journal.pone.0011880.s009
A randomized controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru, PLoS One, vol.10, p.1101, 2007. ,
Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial, Malaria Journal, vol.9, issue.1, p.105, 2010. ,
DOI : 10.1186/1475-2875-9-105
Piperaquine, Drugs, vol.7, issue.1, pp.75-87, 2005. ,
DOI : 10.2165/00003495-200565010-00004
Absence of Association between Piperaquine In Vitro Responses and Polymorphisms in the pfcrt, pfmdr1, pfmrp, and pfnhe Genes in Plasmodium falciparum, Antimicrobial Agents and Chemotherapy, vol.54, issue.9, pp.3537-3544, 2010. ,
DOI : 10.1128/AAC.00183-10
In Vitro Activities of Piperaquine and Other 4-Aminoquinolines against Clinical Isolates of Plasmodium falciparum in Cameroon, Antimicrobial Agents and Chemotherapy, vol.47, issue.4, pp.1391-1394, 2003. ,
DOI : 10.1128/AAC.47.4.1391-1394.2003
In vitro activity of ferroquine (SSR 97193) against Plasmodium falciparum isolates from the Thai-Burmese border, Malaria Journal, vol.6, issue.1, p.81, 2007. ,
DOI : 10.1186/1475-2875-6-81
In Vitro Activities of Piperaquine, Lumefantrine, and Dihydroartemisinin in Kenyan Plasmodium falciparum Isolates and Polymorphisms in pfcrt and pfmdr1, Antimicrobial Agents and Chemotherapy, vol.53, issue.12, pp.5069-5073, 2009. ,
DOI : 10.1128/AAC.00638-09
In Vitro Sensitivities of Plasmodium falciparum to Different Antimalarial Drugs in Uganda, Antimicrobial Agents and Chemotherapy, vol.54, issue.3, pp.1200-1206, 2010. ,
DOI : 10.1128/AAC.01412-09
Ex Vivo Drug Susceptibility of Ferroquine against Chloroquine-Resistant Isolates of Plasmodium falciparum and P. vivax, Antimicrobial Agents and Chemotherapy, vol.55, issue.9, pp.4461-4464, 2011. ,
DOI : 10.1128/AAC.01375-10
to conventional and novel antimalarial drugs in Papua New Guinea, Tropical Medicine & International Health, vol.2, issue.Suppl. 4, pp.342-349, 2010. ,
DOI : 10.1111/j.1365-3156.2009.02463.x
Piperaquine resistance is associated with a copy number variation on chromosome 5 in ,
Efficacy and safety of dihydroartemisinin-piperaquine, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.101, issue.9, pp.858-866, 2007. ,
DOI : 10.1016/j.trstmh.2007.05.018
Clinical and Pharmacological Determinants of the Therapeutic Response to Dihydroartemisinin-Piperaquine for Drug-Resistant Malaria, Antimicrobial Agents and Chemotherapy, vol.51, issue.11, pp.4090-4097, 2007. ,
DOI : 10.1128/AAC.00486-07
Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Malaria: A Randomized Trial, PLoS Clinical Trials, vol.2, issue.5, p.20, 2007. ,
DOI : 10.1371/journal.pctr.0020020.sd002
Randomized Comparison of Amodiaquine plus Sulfadoxine-Pyrimethamine, Artemether-Lumefantrine, and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in Burkina Faso, Clinical Infectious Diseases, vol.45, issue.11, pp.1453-1461, 2007. ,
DOI : 10.1086/522985
Dihydroartemisinin-Piperaquine versus Artesunate-Amodiaquine: Superior Efficacy and Posttreatment Prophylaxis against Multidrug-Resistant Plasmodium falciparum and Plasmodium vivax Malaria, Clinical Infectious Diseases, vol.44, issue.8, pp.1067-1074, 2008. ,
DOI : 10.1086/512677
Pharmacokinetics and Efficacy of Piperaquine and Chloroquine in Melanesian Children with Uncomplicated Malaria, Antimicrobial Agents and Chemotherapy, vol.52, issue.1, pp.237-243, 2008. ,
DOI : 10.1128/AAC.00555-07
Pitfalls in Estimating Piperaquine Elimination, Antimicrobial Agents and Chemotherapy, vol.49, issue.12, pp.5127-5128, 2005. ,
DOI : 10.1128/AAC.49.12.5127-5128.2005
Population pharmacokinetics and therapeutic response of CGP 56697 (artemether+benflumetol) in malaria patients, British Journal of Clinical Pharmacology, vol.41, issue.6 ,
DOI : 10.1046/j.1365-2125.1998.00830.x